Functional PKC in vivo analysis using deficient mouse models

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Protein Kinase C (PKC) signaling pathways are crucial in cellular processes.
• Understanding the in vivo functions of specific PKC isoforms is essential for deciphering their roles in disease.
• Previous studies, particularly those using phorbol 12-myristate 13-acetate (PMA), suggested PKC isoforms might promote tumor development.

Purpose of the Study:

• To elucidate the in vivo functions of individual Protein Kinase C (PKC) isoforms.
• To analyze PKC isoform expression profiles in various mouse tumor models.
• To validate the roles of specific PKC isoforms in tumor development and progression.

Main Methods:

• Generation and analysis of PKC knockout mouse lines.
• Detailed expression analysis of individual PKC isoforms in normal and tumor tissues.
• Crossing PKC knockout mice with tumor-prone genetic backgrounds (e.g., APC(Min)).
• Assessment of tumor growth and progression in PKC-deficient conditions.

Main Results:

• PKC isoform expression is significantly altered (up- or down-regulated) during tumor development and progression.
• PKCalpha-deficient APC(Min) mice exhibited reduced tumor formation, indicating a tumor-suppressive role.
• These findings contradict previous in vitro data suggesting PKCalpha as a tumor promoter.

Conclusions:

• Specific PKC isoforms play critical, context-dependent roles in tumor biology.
• PKCalpha functions as a tumor suppressor in the context of intestinal adenomatous polyposis coli (APC) mutations.
• This research highlights the importance of in vivo studies for understanding complex signaling pathways like PKC in cancer.